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Thromboxane A2 (TXA2) acts on TXA2 receptors (TP) to regulate renal artery blood flow and subsequently contributes to the
pathogenesis of renal ischemia. The present study was designed to examine if nuclear factor-kappaB (NF-𝜅B) signaling pathway
is involved in the downregulation of TP receptors in rat renal artery. Rat renal artery segments were organ cultured for 6 or 24 h.
Downregulation of TP receptors was monitored using myograph (contractile function), real-time PCR (receptor mRNA), and
immunohistochemistry (receptor protein). Specific inhibitors (MG-132 and BMS345541) for NF-𝜅B signaling pathway were used
to dissect the underlying molecular mechanisms involved. Compared to fresh (noncultured) segments, organ culture of the renal
artery segments for 24 h induced a significant rightward shift of U46619 (TP receptor agonist) contractile response curves (pEC50:
6.89±0.06 versus 6.48±0.04, 𝑃 < 0.001).This decreased contractile response to U46619 was paralleled with decreased TP receptor
mRNA and protein expressions in the renal artery smooth muscle cells. Specific inhibitors (MG-132 and BMS345541) for NF-𝜅B
signaling pathway significantly abolished the decreased TP protein expression and receptor-mediated contractions. In conclusion,
downregulation of TP receptors in the renal artery smooth muscle cells occurs mainly via the NF-𝜅B signaling pathway.
1. Introduction
Thromboxane A2 (TXA2) is mainly derived from platelets
and vascular endothelial cells. It acts on TXA2 receptor
(TP) to induce strong vasoconstriction in renal arteries
[1, 2]. Increased renal vascular contractility and resistance
can lead to reduced renal blood flow and subsequent renal
ischemia [3, 4]. During experimental endotoxemic shock,
renal vasoconstriction and ischemia were found to be medi-
ated by TP receptors [3]. In mice with cell-specific deletion
of TP receptors in vascular smooth muscle cells, TP receptor
agonist U46619 failed to induce shock and hypertension, and
angiotensin II-induced hypertension, vascular remodeling,
and urinary thromboxane production were all significantly
attenuated [5]. This indicated that TP receptors play a central
role in the pathogenesis of these diseases. In endotoxemic
mice, inhibition of cyclooxygenase (COX)-1 attenuated the
formation of TXA2 which ameliorated the acute decrease
in glomerular filtration rate [6]. Surgical reduction of renal
mass in TP receptor knockout (TP-R−/−) mice demonstrated
that activation of TP receptors mediated the increase in
endothelin-1 (ET-1), reactive oxygen species (ROS), and
microvascular remodeling and enhanced contractions in
microvessels in chronic kidney disease [7], suggesting that
TXA2 and its receptors were involved in the development of
acute and chronic kidney injury.
On the other hand, TP receptor affinity was reduced
and TP receptor-mediated vasoconstriction was decreased
in gracilis muscle arterioles from pregnant rabbits [8] and
in placentae from human diabetic pregnancies [9]. The
phenomenon of decreased contractile response of vascular
smooth muscle cells to TP receptor agonist U46619 was also
seen in streptozotocin-induced diabetic rats [10]. Interest-
ingly, renal production of TXA2 increased in diabetes [11],
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while TP receptor affinity and the receptor-mediated vaso-
constriction decreased [9, 10]. Thus, the downregulation of
TP receptors in renal vascular smoothmuscle cellsmost likely
serves as a protective mechanism to prevent renal ischemia.
However, there is limited knowledge about the underlying
molecular mechanisms responsible for downregulation of TP
receptor expression.
Previously, we have established an organ culture model
and demonstrated that organ culture of rat renal artery
segments induced activation of nuclear factor-kappaB (NF-
𝜅B) signaling transduction pathway and subsequently upreg-
ulated endothelin type A (ETA) and type B (ETB) receptors in
the smooth muscle cells [12]. The present study was designed
to investigate the underlying molecular mechanisms that are
responsible for the downregulation of TP receptors in rat
renal vascular smooth muscle cells.
2. Material and Methods
The present study followed previously published protocol
by Xie et al. [12] to investigate the downregulation of TP
receptors in rat renal artery.
2.1. Chemicals and Reagents. All chemicals were purchased
from Sigma. U46619 was dissolved in ethanol to obtain a
stock concentration of 10mM and further diluted in distilled
water. MG-132 and BMS345541 were dissolved in dimethyl
sulfoxide (DMSO). Actinomycin D was dissolved in distilled
water.
2.2. Tissue Preparation and Organ Culture Procedure. As pre-
viously described [12], male Sprague-Dawley rats (weighing
300–350 g) were anaesthetized with CO2 and exsanguinated.
The renal artery was gently removed, immersed into cold
buffer solution, and dissected free of adhering tissue under
a microscope. The endothelium was denuded by perfusion
of the vessel with 0.1% Triton X-100 for 10 s followed by
another 10 s with a physiological buffer solution.The removal
of the endothelium was verified by the absence of dilatory
response to acetylcholine (10−6M) in 5-hydroxytryptamine
(10−5M) precontracted segments. The vessels were cut into
1∼1.5mm long cylindrical segments, used directly (fresh
group) or incubated at 37∘C in humidified 5% CO2 in O2
for different time points (organ culture group). Segments for
organ culture were placed in a 24-well plate, one segment
in each well, immersed in 1ml Dulbecco’s modified Eagle’s
medium containing L-glutamine (584mg/l), supplemented
with penicillin (100U/ml) and streptomycin (100 𝜇g/ml). For
inhibition experiments, different inhibitors were added to
the culture medium. The same volume of vehicle served as
control.The experimental protocol was approved by the Lund
University Animal Ethics Committee.
2.3. Buffer Solutions. Standard buffer solution (mM): NaCl
119; KCl 4.6; NaHCO3 15; NaH2PO4 1.2; MgCl2 1.2; CaCl2 1.5;
glucose 5.5. In potassium-rich (60mM K+) buffer solution,
NaCl was replaced by an equimolar concentration of KCl
in the standard solution. Analytical-grade chemicals and
double-distilled water were used for the preparation of all
solutions.
2.4. In Vitro Pharmacology. Fresh or incubated segments
were immersed in a temperature-controlled (37∘C)myograph
system (Organ Bath Model 700MO, J.P. Trading, Aarhus,
Denmark) containing 5ml bicarbonate buffer solution. The
solution was continuously aerated with 5% CO2 in O2
resulting in a pH of 7.4. The renal arterial segments were
mounted for continuous recording of isometric tension by
the Chart software (AD Instruments, Hastings, UK). Before
exposure to potassium-rich buffer solution, a resting tone of
2.0mN was applied to each segment and the segments were
stabilized at this tension for 1.5 h. Resting tone at 2.0mN
is optimal in terms of length/active tension relationship
and performed as previously described [13]. The potassium-
induced contraction was used as a reference for the contrac-
tile capacity, and the segments were used only if potassium
elicited reproducible responses over 1.0mN. Concentration-
response curves of U46619 were obtained by cumulative
administration of the reagents, as previously described [12].
2.5. Real-Time RT-PCR. Total RNA extracted from fresh or
cultured segments was reversely transcribed to cDNA. Real-
time PCR was performed in a GeneAmp 7300 Sequence
Detection system (Perkin-Elmer, Applied Biosystems), using
the GeneAmp SYBR Green kit (Perkin-Elmer, Applied
Biosystems) with a 25 𝜇l reaction volume. The PCR reaction
started at a temperature of 50∘C for 2min, then 95∘C for
10min, followed by 40 PCR cycles with 95∘C for 15 s and
60∘C for 1min. Dissociation curves were obtained after the
PCR cycles to identify the specific PCR products. 𝛽-Actin
was used as housekeeping gene. The gene expressions were
normalized against the housekeeping genes to account for
differences in the starting material and in the cDNA reaction
efficiency.The system automaticallymonitors the binding of a
fluorescent dye to double-strand DNA by real-time detection
of the fluorescence during each cycle of PCR amplification.
Data were analyzed with the comparative cycle threshold
(CT)method.
All primers were designed with the Primer Express 2.0
software (PE Applied Biosystems, CA, USA) and synthesized
by TAG Copenhagen A/S (Copenhagen, Denmark). The
nucleotide sequences of the primers used are shown in
Table 1.
2.6. Immunohistochemistry. Fresh or cultured arterial seg-
ments were immersed in a fixative solution consisting of
4% paraformaldehyde in 0.1M phosphate buffer (pH 7.4) at
4∘C for 3 h. After fixation, the specimens were dehydrated
at 4∘C in phosphate buffer (0.1M, pH 7.4) containing 20%
sucrose for 24 h and then frozen in Tissue-Tek (Sakura
Finetek Europe B.V., Zoeterwoude, The Netherlands) and
stored at −80∘C. Sections were cut into 10 𝜇m thickness
in a cryostat and mounted on SuperFrost Plus slides. The
sections were incubated overnight with rabbit anti-human
TP (Cayman, 10004452, 1 : 200) in PBS with 10% fetal calf
serum. The secondary antibodies were goat-anti-rabbit IgG
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Table 1: Accession numbers and primer sequence for the genes that were investigated.
Gene name Abbreviation Accession number Primer sequence
Thromboxane A2 receptor TP NM 017054.1
Fwd: 5󸀠-ATCTCCCATCTTGCCATAGTCC-3󸀠
Rev: 5󸀠-CCGATGATCCTTGAGCCTAAAG-3󸀠
beta-Actin ACTB NM 031144.2 Fwd: 5
󸀠-GTAGCCATCCAGGCTGTGTTG-3󸀠
Rev: 5󸀠-TGCCAGTGGTACGACCAGAG-3󸀠
FITC conjugated (Santa Cruz, sc-2012, 1 : 200) diluted in
PBS. In control sections, either the primary or the secondary
antibody was omitted. Positive staining in the smoothmuscle
cells was observed under a confocal microscope (C1plus;
Nikon Instruments Inc., Melville, NY, USA) and analyzed by
the Image J software (http://rsb.info.nih.gov/ij).
2.7. Data Analysis. All data are expressed as mean values
± SEM. Unpaired Student’s 𝑡-test or two-way ANOVA with
Bonferroni post test was used when two sets of data were
compared and one-way ANOVA with Dunnett’s multiple
comparison test was used for comparisons of more than 2
data sets. 𝑁-number refers to preparations from different
animals. A 𝑃 value less than 0.05 was considered to be
statistically significant.
3. Results
3.1. Downregulation of TP Receptor mRNA Expression and
Receptor-Mediated Contractions in Renal Artery. Previously,
we have shown that organ culture per se increased vasocon-
tractile responses to ET-1 [12] and noradrenaline [14]; that
is, after organ culture, the concentration-response curves of
ET-1 and noradrenaline shifted to the left, and the maximal
contractions increased [12, 14].
The present study was designed to examine effects of
organ culture per se on TP receptor expression. To study
TP receptor mRNA expression and the receptor-mediated
contractions, rat renal artery ring segments were cultured
in the serum-free culture medium for 6 or 24 h. U46619
induced strong concentration-dependent contractions in
fresh (noncultured) segments. Organ culture for 6 h made
the contractile response curves of U46619 shift to the right,
but the shift did not reach the statistical significance (pEC50:
6.89 ± 0.06 versus 6.73 ± 0.03, 𝑃 > 0.05, Figure 1(a)) and
therewere no significant changes in themaximal contractions
(𝐸max: 158.2 ± 6.6 versus 152.9 ± 3.9, 𝑃 > 0.05, Figure 1(a)).
After 24 h of organ culture, there was a significant rightward
shift inU46619 contractile response curves (pEC50: 6.89±0.06
versus 6.48 ± 0.04, 𝑃 < 0.001, Figure 1(a)), demonstrating
downregulation of TP receptors in the renal artery smooth
muscle cells.
K+-induced contraction was used as a reference of the
contractile capacity. There was no significant difference in
the K+-induced contractions before and after organ culture
(before 1.62 ± 0.15mN versus after 1.69 ± 0.22mN, 𝑛 = 14,
𝑃 > 0.05).
The downregulation of TP receptor-mediated contrac-
tions was paralleled with significantly decreased TP receptor
mRNA expression after 24 h of organ culture (Figure 1(b),
𝑃 < 0.01), suggesting involvement of transcriptional
mechanisms. This was further supported by the fact that
a general transcriptional inhibitor actinomycin D (ACD
5mg/L) normalized the downregulation of TP receptor-
mediated contractions (Figure 2).
3.2. Inhibitors for NF-𝜅B Signaling Pathway Reversed the TP
Receptor Downregulation. I𝜅B kinase (IKK) is part of the
upstream NF-𝜅B signaling transduction cascade. It phos-
phorylates the inhibitory I𝜅B𝛼 protein and subsequently
results in the dissociation of I𝜅B𝛼 from NF-𝜅B, allowing
free NF-𝜅B to translocate into the nucleus to induce gene
expressions. In our established organ culture model, only
a faint expression of the phosphorylated IKK protein was
demonstrated in the renal artery smoothmuscle cells of fresh
segments (before organ culture), while after organ culture, the
expression of the phosphorylated IKK protein significantly
increased, indicating that organ culture per se activated NF-
𝜅B signaling transduction pathway [12]. In addition, Western
blot experiments showed that organ culture per se time-
dependently induced phosphorylation of NF-𝜅B in smooth
muscle cells, and migration of NF-𝜅B from the cytoplasm to
the nucleus [15]. In the present study, the same model was
used with two specific NF-𝜅B signaling pathway inhibitors:
MG-132 (0.2, 1, and 5𝜇M), which is ubiquitin-proteasome
inhibitor that inhibits NF-𝜅B nuclear translocation [16], and
BMS345541 (1, 5, and 25 𝜇M), which is an I𝜅B inhibitor
[17]. Both MG-132 (Figure 3(a), Table 2) and BMS345541
(Figure 3(b), Table 2) concentration-dependently reversed
the downregulation of TP receptor-mediated contractions.
In addition, BMS345541 (5 𝜇M) significantly abolished
the decreased TP receptor mRNA expression (Figure 3(c)).
However, MG-132 (1𝜇M) surprisingly did not affect TP
receptor mRNA expression (Figure 3(c)).
3.3. Regulation of TP Receptor Protein Expression. TP recep-
tor protein expression was investigated by immunohisto-
chemistry in the renal artery segments after removal of
the endothelium. Strong TP receptor protein immunoreac-
tion (expression) with bright green granules located in the
smooth muscle cells was seen in fresh controls (nonculture,
Figure 4(a)). Organ culture for 24 h resulted in decreased
TP receptor protein expression in the smooth muscle cells
(Figure 4(b)). Semiquantitative measurement of the recep-
tor protein densities using Image J software showed that
inhibition of NF-𝜅B signaling pathway using MG-132 or
BMS345541 significantly reversed the downregulation of TP
receptor protein expressions (Figure 4(c)).
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Figure 1: (a) Contractile responses to U46619 in the fresh segments or following organ culture for 6 or 24 h. Data are shown as means ± SEM
(𝑛 = 8–16). Two-way ANOVA with Bonferroni post test was used. ∗𝑃 < 0.05, ∗∗∗𝑃 < 0.001 versus fresh. (b) TP receptor mRNA expression
in fresh renal arterial segments or organ cultured for 24 h. Data are shown as means ± SEM (𝑛 = 6–8). Unpaired Student’s 𝑡-test was used.
∗∗
𝑃 < 0.01 versus fresh. Fresh = noncultured segments; OC 6 h = organ cultured for 6 h; OC 24 h = organ cultured for 24 h.
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Figure 2: Effects of the transcriptional inhibitor actinomycin D (ACD 5mg/L) on U46619-induced contraction. The artery segments were
organ cultured in the presence of vehicle or ACD (5mg/L) for 24 h. Fresh = noncultured segments. Data are shown as means ± SEM. Each
data point is derived from 4–8 experiments.
Advances in Pharmacological Sciences 5
0
50
100
150
250
200
C
on
tr
ac
tio
n 
(%
 o
f＋
+
)
−8 −7 −6 −5−9
U46619 (logM)
Vehicle
－＇-132 5 －
－＇-132 1 －
－＇-132 0.2 －
(a)
BMS 25 M
BMS 5M
BMS 1 M
0
50
100
150
250
200
C
on
tr
ac
tio
n 
(%
 o
f＋
+
)
Vehicle
−8 −7 −6 −5−9
U46619 (logM)
(b)
n.s
BMS 5M
∗
0.000
0.005
0.010
0.015
A
m
ou
nt
 o
f T
P 
re
ce
pt
or
 m
RN
A
 re
lat
iv
e t
o 

-a
ct
in
Vehicle MMG 1
(c)
Figure 3: Effect of NF-𝜅B inhibitors (a) MG-132 and (b) BMS345541 on U46619-induced contraction and TP receptor (c) mRNA expression.
Renal artery segments were organ cultured in presence of vehicle (DMSO) or different concentrations of MG-132 (MG, 0.2, 1, or 5𝜇M) or
BMS345541 (BMS, 1, 5, or 25 𝜇M) for 24 h. Data are shown asmeans ± SEM. Each data point is derived from 6 experiments. One-way ANOVA
with Dunnett’s multiple comparison test was used. ∗𝑃 < 0.05 versus vehicle (DMSO) and n.s. = not significant. BMS = BMS345541, MG =
MG-132.
4. Discussion
Under physiological conditions, TP receptors play an impor-
tant role in maintenance of renal blood flow, mediation of
renin release, and regulation of sodium excretion [4]. During
renal ischemia, TP receptormediates renal artery contraction
and contributes to increased kidney injury [3]. The present
study has demonstrated that organ culture of renal artery
segments induced downregulation of TP receptor expressions
with decrease in receptor-mediated contraction in renal
artery smoothmuscle cells. Furthermore, the downregulation
of TP receptor expressions occurred mainly via activation
of NF-𝜅B signaling pathway. Our findings suggest that the
organ culture method provides a model to study molecular
mechanisms that are responsible for the regulation of TP
receptor expressions. The downregulation of TP receptor
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Figure 4: TP receptor protein expression in the fresh segments (a) and following organ culture for 24 h (b). The arteries were denuded
of endothelium; the innermost autofluorescent inner elastic membrane is easily depicted (arrow head). The smooth muscle cell protein
expression is homogenously distributed (arrow). L indicates lumen. The scale bar = 100 𝜇m. The protein expression was quantified using
the program Image J software (c). Each data point is derived from 6 experiments. Unpaired Student’s 𝑡-test was used. ∗∗∗𝑃 < 0.001 versus
fresh; #𝑃 < 0.05, ##𝑃 < 0.01 versus vehicle.
expressions may contribute to modulation of renal artery
blood flow and serve as a feedback mechanism in the
pathogenesis of renal ischemia.
TXA2 acts on TP receptors in renal smooth muscle cells
to induce renal vascular contraction. Infusion of angiotensin
II at a slow pressor rate caused renal vasoconstriction and
hypertension [18], which was prevented by deletion of the
gene for TP receptors in the vascular smooth muscle cells
[5], suggesting that the slow pressor dose of angiotensin
II infusion could increase production of TXA2 and subse-
quently induce renal vasoconstriction [18, 19]. In the present
study, organ culture of renal artery for 6 and 24 h resulted
in time-dependent downregulation of TP receptor expression
in the renal smooth muscle cells and subsequently decreased
contractile response to U46619. A general transcription
inhibitor actinomycin D normalized the downregulation of
TP receptor-mediated contractions, suggesting involvement
of transcriptionalmechanisms. Inhibition ofNF-𝜅B signaling
pathway by using MG-132 and BMS345541 significantly
abolished the downregulation of TP receptor-mediated con-
tractions as well as the decrease in receptor mRNA and
protein expressions in smooth muscle cells, suggesting that
the downregulation of TP receptors occurred mainly via
activation of NF-𝜅B signaling transduction pathway.
BMS345541 significantly abolished the decreased TP
receptor mRNA expression, while MG-132 did not signif-
icantly affect TP receptor mRNA expression. This might
be due to complex mechanisms involved in the regulation
of TP receptor mRNA and protein expressions. In fact,
not only is protein expression controlled by transcriptional
mechanisms [20], but posttranscriptional, translational, and
protein degradationmechanisms are also involved in the con-
trol of steady-state protein abundances [21]. Similar mRNA
expression patterns could be accompanied by large variations
(more than 20-fold difference) of protein abundances, and
vice versa [22]. Thus, mRNA expression poorly predicts the
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Table 2: Maximal contractile response (𝐸max) and pEC50 values
to U46619 in rat renal arteries following organ culture for 24 h in
presence of vehicle (DMSO) or different concentration of NF-𝜅B
inhibitors.
Groups 𝑛 U46619
𝐸max (%) pEC50
Vehicle 6 113.7 ± 2.30 6.52 ± 0.02
MG 0.2 𝜇M 6 140.1 ± 3.35∗ 6.71 ± 0.03∗
MG 1 𝜇M 6 161.3 ± 5.23∗∗∗ 6.86 ± 0.04∗∗∗
MG 5𝜇M 6 200.6 ± 9.25∗∗∗ 6.90 ± 0.07∗∗∗
vehicle 6 129.3 ± 4.19 6.41 ± 0.04
BMS 1 𝜇M 6 130.7 ± 5.52 6.75 ± 0.07
BMS 5 𝜇M 6 125.8 ± 7.49 7.06 ± 0.10∗∗
BMS 25 𝜇M 6 143.7 ± 11.68 7.09 ± 0.16∗∗∗
Overview of𝐸max and pEC50 values of U46619-induced contractile response
on rat renal arteries. The segments were organ cultured for 24 h in presence
of vehicle (control) or different concentrations of MG-132 (MG 0.2, 1, or
5𝜇M) or BMS345541 (BMS 1, 5, or 25 𝜇M). Data are shown as mean ± SEM.
𝑛 denotes the number of vessel segments. One-way ANOVA with Dunnett’s
multiple comparison test was used. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001
versus vehicle.
corresponding protein expression level, and mRNA-protein
expression correlationmight also vary in different treatments.
Increased renal artery contractility leads to reduced renal
bloodflowand subsequent renal ischemia, which is often seen
in renal vasospasm [23] and endotoxemic shock-induced
renal injury [3]. On the other hand, downregulation of TP
receptors occurs in pregnancy and diabetes [8–10]. In the
present study, organ culture per se induced downregulation of
TP receptors in rat renal smooth muscle cells. This simulates
TP receptor downregulation which is a phenomenon seen in
pregnancy and diabetes [8–10]. Thus, organ culture method
may be a useful model for studying the underlying molecular
mechanisms responsible for regulation of the TP receptor
expression.
5. Conclusion
Organ culture simulates TP receptor downregulation, which
is a phenomenon seen in pregnancy and diabetes [8–10].
Downregulation of TP receptors in renal artery smooth
muscle cells mainly occurs via NF-𝜅B signaling transduction
pathway-mediated transcriptional mechanisms and might
contribute tomodulation of renal artery blood flow and serve
as a protective feedbackmechanism to prevent renal ischemia
and kidney injury.
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